GREAT POINT PARTNERS LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 116 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2016$5,254,000
-15.2%
978,350
-27.3%
1.50%
-32.3%
Q1 2016$6,193,000
-7.1%
1,346,344
+5.0%
2.22%
-20.6%
Q4 2015$6,669,000
-17.4%
1,282,527
-3.9%
2.80%
-12.4%
Q3 2015$8,077,0001,335,0003.20%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2016
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders